Etanercept induced organizing pneumonia in a patient with rheumatoid arthritis.
Rheumatol Int
; 32(4): 1055-7, 2012 Apr.
Article
en En
| MEDLINE
| ID: mdl-20062996
ABSTRACT
TNF inhibitors are being used in a rapidly expanding number of rheumatoid arthritis (RA) patients due to their effectiveness and acceptable safety profiles. To date, concerns regarding the adverse effects of TNF inhibitors have focused on infections, hematologic malignancies, and demyelinating disorders. Recently, the development of autoantibodies and other autoimmunity has been increasingly reported. Here, we describe a 36-year-old RA patient in whom organizing pneumonia and systemic lupus erythematosus were detected during etanercept treatment.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Artritis Reumatoide
/
Inmunoglobulina G
/
Receptores del Factor de Necrosis Tumoral
/
Neumonía en Organización Criptogénica
/
Antirreumáticos
Límite:
Adult
/
Female
/
Humans
Idioma:
En
Revista:
Rheumatol Int
Año:
2012
Tipo del documento:
Article